[go: up one dir, main page]

Panda et al., 2013 - Google Patents

Design and evaluation of zidovudine loaded natural biodegradable microcapsules employing colophony resin as microencapsulating agent

Panda et al., 2013

View PDF
Document ID
7085432226361534874
Author
Panda S
Pattnaik S
Maharana L
Botta G
Mahapatra A
Publication year
Publication venue
Int. J. Phar. Pharm. Sci

External Links

Snippet

The aim of the present study is to develop and evaluate natural biodegradable microcapsules of zidovudine (AZT) by using colophony resin as microencapsulating agent, which after oral administration could improve the bioavailability of the drug, in order to …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Basu et al. Preparation and characterization of nitrendipine-loaded Eudragit RL 100 microspheres prepared by an emulsion-solvent evaporation method
DK159716B (en) INHALATION POWDER, PROCEDURE FOR PREPARING IT AND PHARMACEUTICAL FORMULA CONTAINING SUCH
UA110773C2 (en) Method of producing powder containing nano- and microparticles
DE3024858A1 (en) CONTINUOUSLY RELEASING PHARMACEUTICAL PREPARATION OF A SOLID MEDICINAL MATERIAL
Abdallah et al. Development and characterization of controlled release ketoprofen microspheres
US20180338927A1 (en) Ether cellulose derivative microparticle
Pohlen et al. Preparation, physicochemical characterisation and DoE optimisation of a spray-dried dry emulsion platform for delivery of a poorly soluble drug, simvastatin
Mali et al. Microencapsulation: A review
Letchmanan et al. Application of transglycosylated stevia and hesperidin as drug carriers to enhance biopharmaceutical properties of poorly-soluble artemisinin
ES2584403T3 (en) Process for the preparation of enteric alginate microcapsules by ionic gelation containing diclofenac or one of its salts and multiparticulate pharmaceutical composition containing them
Panda et al. Design and evaluation of zidovudine loaded natural biodegradable microcapsules employing colophony resin as microencapsulating agent
EP1469835B1 (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
RU2351352C2 (en) Solid nanocomposition for delivery of biologically active substances
CN106999429A (en) Nanoparticle suspension agent formulation
Abbaspour et al. Preparation and Evaluation of Berberine-Excipient Complexes in Enhancing the Dissolution Rate of Berberine Incorporated into Pellet Formulations
Karthika et al. Formulation development and In vitro characterization of solid self nano emulsifying drug delivery system for curcumin to target colon adenocarcinoma
Patel et al. Formulation and evaluation of metformin hydrochloride microparticles by emulsion solvent evaporation technique
Patil et al. Development and evaluation of sustain release simvastatin pellets
Bal et al. Preparation and evaluation of mucoadhesive simvastatin microcapsules using orifice gelation technique
Panda et al. Fabrication of Zidovudine Loaded Olibanum Resin Microcapsules: Employing Natural Resin as Controlled Release Coat Material
Thorat et al. Fast dissolving drug delivery system of cilnidipine using gelucire 50/13
Priya Self-emulsifying systems of Aceclofenac by extrusion/Spheronization: Formulation and evaluation
CN1822818B (en) Particles containing an acitve agent in the form of a co-precipitate
Panda et al. Formulation And In-Vitro Characterization Of Lamivudine Embedded Natural Resin Microspheres Using Olibanum As Drug Carriers
Patil et al. Utilization of Natural Olibanum Gum Resin as a Rate Controlling Polymer in Design and Evaluation of Microspheres of an Antiretroviral Drug by using a Unique Spray Drying Technique